Journal
HEART RHYTHM
Volume 9, Issue 8, Pages 1310-1318Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hrthm.2012.04.020
Keywords
Biological pacemaker; In vivo gene transfer; Preclincal large animal model; Pacemaker device infection; Temporary pacing
Categories
Funding
- Cedars Sinai Heart Institute
Ask authors/readers for more resources
BACKGROUND Pacemaker-dependent patients with device infection require temporary pacing while the infection is treated. External transthoracic pacing is painful and variably effective, while temporary pacing leads are susceptible to superinfection. OBJECTIVE To create a biological pacemaker delivered via venous catheters in a porcine model of complete heart block, providing a temporary alternative/adjunct to external pacing devices without additional indwelling hardware. METHODS Complete atrioventricular (AV) nodal block was induced in pigs by radiofrequency ablation after the implantation of a single-chamber electronic pacemaker to maintain a ventricular backup rate of 50 beats/min. An adenoviral vector cocktail (K-AAA + H2), expressing dominant-negative inward rectifier potassium channel (Kir2.1AAA) and hyperpolarization-activated cation channel (HCN2) genes, was injected into the AV junctional region via a NOGA Myostar catheter advanced through the femoral vein. RESULTS Animals injected with K-AAA + H2 maintained a physiologically relevant ventricular rate of 93.5 +/- 7 beats/min (n = 4) compared with control animals (average rate, 59.4 +/- 4 beats/min; n = 6 at day 7 postinjection; P < .05). Backup electronic pacemaker utilization decreased by almost 4-fold in the K-AAA + H2 group compared with the control (P < .05), an effect maintained for the entire 14-day window. In contrast to the efficacy of gene delivery into the AV junctional region, open-chest, direct injection of K-AAA + H2 (or its individual vectors) into the ventricular myocardium failed to elicit significant pacemaker activity. CONCLUSIONS The right-sided delivery of K-AAA + H2 to the AV junctional region provided physiologically relevant biological pacing over a 14-day period. Our approach may provide temporary, bridge-to-device pacing for the effective clearance of infection prior to the reimplantation of a definitive electronic pacemaker.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available